Presentation Information
[28P-am500S]Evaluation of the Risk of Pancreatic Cancer Associated with Dipeptidyl Peptidase-4 Inhibitors Using the Prevalent User : A Methodological Investigation in Epidemiology
○Manato Yoshida1, Takuma Koinuma2, Manabu Akazawa 1 (1. Meiji Pharmaceutical University, 2. Tokyo University of Pharmacy and Life Sciences)
Password required to view
Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.
The password will be emailed to those who have completed the registration.